These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 19076931)

  • 1. Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment.
    van Rensen EL; Evertse CE; van Schadewijk WA; van Wijngaarden S; Ayre G; Mauad T; Hiemstra PS; Sterk PJ; Rabe KF
    Allergy; 2009 Jan; 64(1):72-80. PubMed ID: 19076931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
    Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV
    Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
    Diamant Z; Kuperus J; Baan R; Nietzmann K; Millet S; Mendes P; Miller B; Amin D; Rohatagi S; Sterk PJ; Hoogsteden HC; Prins JB
    Clin Exp Allergy; 2005 Aug; 35(8):1080-7. PubMed ID: 16120091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
    Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK
    Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
    Louw C; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbroker D; Bardin PG
    Respiration; 2007; 74(4):411-7. PubMed ID: 16954654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge.
    Schubert R; Kitz R; Beermann C; Rose MA; Lieb A; Sommerer PC; Moskovits J; Alberternst H; Böhles HJ; Schulze J; Zielen S
    Int Arch Allergy Immunol; 2009; 148(4):321-9. PubMed ID: 19001792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum inflammatory cells and allergen-induced airway responses in allergic asthmatic subjects.
    Imaoka H; Gauvreau GM; Watson RM; Strinich T; Obminksi GL; Howie K; Killian KJ; O'Byrne PM
    Allergy; 2011 Aug; 66(8):1075-80. PubMed ID: 21447082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.
    Noga O; Hanf G; Brachmann I; Klucken AC; Kleine-Tebbe J; Rosseau S; Kunkel G; Suttorp N; Seybold J
    J Allergy Clin Immunol; 2006 Jun; 117(6):1493-9. PubMed ID: 16751018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
    Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF
    Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab protects against allergen- induced bronchoconstriction in allergic (immunoglobulin E-mediated) asthma.
    Zielen S; Lieb A; De La Motte S; Wagner F; de Monchy J; Fuhr R; Munzu C; Koehne-Voss S; Rivière GJ; Kaiser G; Erpenbeck VJ
    Int Arch Allergy Immunol; 2013; 160(1):102-10. PubMed ID: 22948442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response.
    Luijk B; van den Berge M; Kerstjens HA; Postma DS; Cass L; Sabin A; Lammers JW
    Allergy; 2008 Jan; 63(1):75-80. PubMed ID: 17944983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses.
    Gauvreau GM; Hessel EM; Boulet LP; Coffman RL; O'Byrne PM
    Am J Respir Crit Care Med; 2006 Jul; 174(1):15-20. PubMed ID: 16574937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
    Lin H; Boesel KM; Griffith DT; Prussin C; Foster B; Romero FA; Townley R; Casale TB
    J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
    Subbarao P; Dorman SC; Rerecich T; Watson RM; Gauvreau GM; O'Byrne PM
    J Allergy Clin Immunol; 2005 Apr; 115(4):745-50. PubMed ID: 15805993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The occurrence of late asthmatic response to exercise after allergen challenge.
    Koh YY; Jeong JH; Jin SM; Kim CK; Min KU
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):366-72. PubMed ID: 9809502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.